Sadegh Babashah - Genetic Mutations

Author Information

Sadegh Babashah is affiliated with the Department of Molecular Genetics at the Faculty of Biological Sciences, Tarbiat Modares University, located in Tehran, Iran. His research work is focused on various aspects of genetics, with a particular emphasis on cancer genetics, non-coding RNAs, and cellular mechanisms in different types of cancer.

Research Contributions

Dr. Sadegh Babashah has made significant contributions to the field of genetics, particularly in understanding the genetic underpinnings of various types of cancers. His research includes strategies to mitigate the side effects of chimeric antigen receptor T cell therapy, whole-transcriptome analysis for genetic diagnosis of Mendelian skin disorders, and exploring microRNA signatures as potential diagnostic biomarkers in colorectal and breast cancers. Additionally, his work on non-coding RNA-associated competitive endogenous RNA regulatory networks presents novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. His research on SMAD4 expression in renal cell carcinomas and its correlation with stem-cell phenotype and poor clinical outcomes further underscores his expertise in cancer genetics.

Aliases

S. Babashah is also known by the aliases S Babashah, S. Babashah, and Sadegh Babashah.

Publication and Citation Metrics

Metric	Value
Total Papers	93
Total Citations	1799
h-index	21
Recent Publications	Strategies to overcome the side effects of chimeric antigen receptor T cell therapy (2022) Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity (2021) Anatomical Studies of Genetic Variation Instabilities in Various Cancer (2021) Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma (2021) Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues (2021) Up-regulation of miR-155 potentiates CD34+ CML stem/progenitor cells to escape from the growth-inhibitory effects of TGF-β1 and BMP signaling (2021) Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma (2021) SMAD4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes (2021) Use of cellular exosomes as a new carrier in breast cancer gene therapy (2021) SMAD4 contributes to chondrocyte and osteocyte development (2021)